Clinical Trial Update: Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating capecitabine in combination with irinotecan for locally advanced, recurrent, or metastatic colorectal cancer has completed. Results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-04-15